- Buried penis
- Urolithiasis
- Cryptorchidism
- Penile Curvature
- Gender Dysforia
- Erectile dysfunction
- Dysmorphophobia
- Premature Ejaculation
- Phimosis
- Short frenulum
- Hydrocele
- Female urinary incontinence
- Male urinary incontinence
- Male Infertility
- Urinary infections
- Benign prostatic hypertrophy
- Hypogonadism
- Hypospadias
- Sexually transmitted diseases (MST)
- Micropenis
- Prostatitis
- Urethral strictures
- Penile cancer
- Kidney cancer
- Testicular Cancer
- Prostate cancer
- Bladder cancer
- Varicocele
Bladder cancer
Bladder cancer is the seventh most common cancer in men worldwide and the tenth when considering both sexes.
It is a complex and multifactorial disease that recognizes several risk factors:
- Tobacco: The hydrocarbons contained in tobacco smoke are excreted through the kidneys, increasing the risk of bladder cancer. As the duration and intensity of tobacco use increase, the risk of developing bladder tumors significantly rises.
- Occupational exposure: Exposure to chemicals such as amines and hydrocarbons, which mainly occurs in industrial plants processing paints and metals, is the second most important risk factor.
- Radiation
These factors underline the importance of prevention, both through reducing tobacco consumption and implementing safety measures in the workplace.
DIAGNOSIS
Bladder cancer is a clinical condition that requires accurate and timely diagnosis due to its potential development and possible complications.
Hematuria, or the presence of blood in the urine, is the primary and most common symptom. This may be accompanied, although less frequently, by sensations of pain and burning during urination.
Diagnosis begins with taking a detailed medical history, where it is essential to identify risk factors such as smoking history, exposure to chemicals, and the presence of recurrent urinary infections.
Imaging plays a crucial role in diagnosis:
- Abdominal ultrasound may not be sufficient to identify small lesions.
- Cystoscopy is the reference examination, as it allows direct visualization of the bladder mucosa and thus provides a clear assessment of the location and extent of the disease.
Bone scintigraphy and uro-CT are particularly useful for evaluating possible tumor infiltration into surrounding tissues and for identifying distant metastases, thereby contributing to targeted therapeutic planning.
TRATTAMENTO
Il trattamento chirurgico del tumore della vescica può variare notevolmente a seconda delle caratteristiche specifiche del tumore stesso.
Per i tumori non infiltranti e di piccole dimensioni, la resezione endoscopica vescicale transuretrale (TURBT) è una procedura comune e meno invasiva, che permette di rimuovere il tumore e di preservare la vescica. Per quelli infiltranti, invece, la cistectomia radicale è la scelta appropriata, comportando l’asportazione totale della vescica.
In cases of advanced or inoperable metastatic tumors, chemotherapy becomes the first-line treatment. Modern therapeutic options have evolved toward integrated approaches, combining surgery with chemotherapeutic, immunotherapeutic, and radiotherapy, depending on clinical needs and tumor characteristics.
The treatment of bladder tumors is therefore highly personalized and is based on a combination of surgical techniques and pharmacological treatments, tailored to the specific needs of each patient.
Facing a cancer diagnosis can lead to a range of emotions, including fear, anxiety, and depression. Additionally, physical changes related to treatment can affect self-perception and quality of life. For this reason, medical support should always be accompanied by emotional support to help address the emotions and concerns related to the disease.
View also: